Tyra Biosciences (TYRA) Interest & Investment Income (2020 - 2026)
Quarterly Interest & Investment Income fell 27.28% to $2.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Mar 2026, down 31.74% year-over-year, with the annual reading at $12.8 million for FY2025, 27.58% down from the prior year.
Tyra Biosciences filings provide 7 years of Interest & Investment Income readings, the most recent being $2.7 million for Q1 2026.
- Interest & Investment Income hit $2.7 million in Q1 2026 for Tyra Biosciences, roughly flat from $2.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.8 million in Q2 2024 and bottomed at $18000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $2.8 million, with a median of $2.8 million recorded in 2023.
- The largest annual shift saw Interest & Investment Income surged 56450.0% in 2022 before it tumbled 35.73% in 2025.
- Tyra Biosciences' Interest & Investment Income stood at $2.2 million in 2022, then surged by 30.06% to $2.8 million in 2023, then surged by 48.82% to $4.2 million in 2024, then tumbled by 35.73% to $2.7 million in 2025, then increased by 0.41% to $2.7 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Interest & Investment Income are $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.69 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 4.17 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 2.81 Mn |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | 2.45 Mn |
| Dec 31, 2022 | 2.16 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 346,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | -2,000.00 |